CPT® Code 0619T

1. Indications

The procedure described by CPT® Code 0619T is indicated for patients experiencing urinary symptoms due to benign prostatic hypertrophy (BPH). These symptoms may include:

• Urinary Obstruction: Difficulty in urination due to the enlargement of the prostate, which compresses the urethra.
• Increased Urinary Frequency: A need to urinate more often than usual, particularly during the night (nocturia).
• Weak Urinary Stream: A decrease in the force of the urine stream, making it challenging to empty the bladder completely.
• Urgency: A sudden, strong need to urinate that may lead to incontinence.

2. Procedure

The procedure involves several key steps to ensure effective treatment of urinary symptoms associated with BPH:

• Step 1: Cystourethroscopy Setup - The patient is positioned appropriately, and local or general anesthesia may be administered. A cystoscope is then inserted through the urethra to visualize the bladder and the surrounding prostatic area.
• Step 2: Visualization - The cystoscope allows the physician to examine the prostate and the urethra closely, identifying the anterior prostatic commissure and bladder neck that require intervention.
• Step 3: Commissurotomy - Using electrical current or laser energy, the physician creates one or two small grooves in the tissue at the junction of the prostate and bladder. This step divides the anterior prostatic commissure, effectively relieving the obstruction.
• Step 4: Drug Delivery - After the commissurotomy, a catheter is used to deliver a drug to the prostatic urethra. This drug is intended to maintain the patency of the urinary channel and prevent re-obstruction.
• Step 5: Use of Optilume™ BPH Catheter System - In cases where the Optilume™ system is employed, a predilation balloon catheter is passed through the urethra. This balloon exerts radial force to dilate the prostatic urethra, achieving the commissurotomy without traditional cutting methods.
• Step 6: Inflation of Drug-Coated Balloon - A drug-coated balloon catheter is introduced, which contains paclitaxel. Upon inflation, the balloon transfers the drug to the lining of the urethra, promoting sustained opening of the newly divided tissue.

3. Post-Procedure

Post-procedure care following cystourethroscopy with transurethral anterior prostate commissurotomy includes monitoring for any immediate complications such as bleeding or infection. Patients may experience some discomfort or urinary urgency following the procedure, which is typically managed with analgesics. It is essential for patients to follow up with their healthcare provider to assess the effectiveness of the procedure and to monitor for any potential recurrence of symptoms. Instructions regarding hydration, activity level, and signs of complications should be provided to ensure a smooth recovery process.